JUPITER NEUROSCIENCES INC (JUNS) Peer Comparison

$4.89

$-0.12 (-2.40%)

As on 27-Aug-2026 16:01EDT

Market cap

$5 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

227.7

Div. Yield

0 %

Edit

	JUPITER NEUROSCIENCES INC (JUNS)	Zai Lab - ADR	HUTCHMED (China) - ADR	DBV Technologies S.A. - ADR	Pharming Group N.V. ADS each representing 10 (PHAR)
Market cap ($ Mln)	5	2,920	2,195	914	839
Revenue ($ Mln)	0	450	549	--	366
Net Profit ($ Mln)	-9.20	-188.21	17.88	-175.85	9.27
Net Margin (%)	-14,220.12	-41.86	3.26	--	2.53
RoE (%)	--	-28.46	1.43	-106.84	3.39
Price to Earnings	--	--	126.30	--	84.64
Price-To-Book	227.66	4.82	1.73	5.59	3.06

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	JUPITER NEUROSCIENCES INC (JUNS)	Zai Lab - ADR	HUTCHMED (China) - ADR	DBV Technologies S.A. - ADR	Pharming Group N.V. ADS each representing 10 (PHAR)
Operating Revenue	0.06	449.61	549.12	0.00	366.45
Cost of Revenue	0.01	195.71	548.01	12.78	49.36
Gross Profit	0.02	269.08	212.72	-17.67	330.63
Operating Expenses	9.87	517.90	35.89	176.86	304.74
Operating Profit (EBIT)	-9.81	-264.00	-34.78	-181.14	12.35
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-9.20	-190.72	20.08	-178.93	15.84
Provision for Tax	0.00	-2.51	1.66	-3.09	6.57
Profit after Tax (Net Income)	-9.20	-188.21	17.88	-175.85	9.27
Minority Interest	0.00	0.00	0.00	0.00	0.00
Consolidated Profit	0.00	0.00	0.00	0.00	0.00

Liabilities ($ Mln)

	JUPITER NEUROSCIENCES INC (JUNS)	Zai Lab - ADR	HUTCHMED (China) - ADR	DBV Technologies S.A. - ADR	Pharming Group N.V. ADS each representing 10 (PHAR)
Shareholder's Funds	-0.37	607.04	1,260.78	160.40	270.49
Minority Interest	0.00	0.00	0.00	0.00	0.00
Non-Current Liabilities	0.21	39.17	186.25	8.50	104.25
Current Liabilities	3.88	428.58	275.21	54.30	93.25
Total Liabilities	5.56	1,172.38	1,753.10	233.72	499.81

Assets ($ Mln)

	JUPITER NEUROSCIENCES INC (JUNS)	Zai Lab - ADR	HUTCHMED (China) - ADR	DBV Technologies S.A. - ADR	Pharming Group N.V. ADS each representing 10 (PHAR)
Non-Current Assets	1.17	160.76	183.02	21.30	187.30
Current Assets	2.55	914.04	1,553.41	201.90	280.69
Total Assets	5.56	1,172.38	1,753.10	233.72	499.81
Total Debt*	1.75	254.58	94.51	21.00	113.30
Net Current Assets	0.00	485.45	0.00	147.60	187.44

Cashflow ($ Mln)

	JUPITER NEUROSCIENCES INC (JUNS)	Zai Lab - ADR	HUTCHMED (China) - ADR	DBV Technologies S.A. - ADR	Pharming Group N.V. ADS each representing 10 (PHAR)
Cash From Operating Activities	-5.41	-150.79	-64.66	-121.18	54.71
Cash Flow from Investing Activities	--	307.87	-29.41	-1.37	26.25
Cash from Financing Activities	5.43	72.35	7.84	276.18	1.50
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	JUPITER NEUROSCIENCES INC (JUNS)	Zai Lab - ADR	HUTCHMED (China) - ADR	DBV Technologies S.A. - ADR	Pharming Group N.V. ADS each representing 10 (PHAR)
ROCE (%)	-219.49	-18.15	41.92	-130.25	0.77
ROE (%)	-738.83	-28.46	1.43	-106.84	3.39
ROA (%)	-143.03	-12.55	0.66	-74.77	1.69
EBIT Margin (%)	0.00	-41.09	-6.33	--	8.34
Net Margin (%)	-14,220.12	-41.86	3.26	--	2.53
Cash Profit Margin (%)	--	0.00	--	--	0.00

Growth Ratios

	JUPITER NEUROSCIENCES INC (JUNS)	Zai Lab - ADR	HUTCHMED (China) - ADR	DBV Technologies S.A. - ADR	Pharming Group N.V. ADS each representing 10 (PHAR)
Revenue Growth (%)	--	5.10	-8.81	-1.00	-99.61
EBIT Growth (%)	--	11.36	-76.55	-45.21	523.06
Net Profit Growth (%)	-55.91	11.44	-96.17	-43.04	-99.68
EPS Growth (%)	-266.78	-1.87	-96.17	7.30	-96.78
Book Value Growth (%)	-121.67	-25.05	2.54	108.85	7.71

Valuation Ratios

	JUPITER NEUROSCIENCES INC (JUNS)	Zai Lab - ADR	HUTCHMED (China) - ADR	DBV Technologies S.A. - ADR	Pharming Group N.V. ADS each representing 10 (PHAR)
Price / Earnings	-0.05	-11.11	5.08	-9.99	469.58
Price / Book Value	-0.26	2.73	1.88	8.70	4.83
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	-0.23	-9.39	-25.58	-9.30	36.65
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	JUPITER NEUROSCIENCES INC (JUNS)	Zai Lab - ADR	HUTCHMED (China) - ADR	DBV Technologies S.A. - ADR	Pharming Group N.V. ADS each representing 10 (PHAR)
Debt to Equity	0.00	0.00	0.00	0.00	0.34
Short term debt to equity ratio	-4.22	0.40	0.02	0.09	0.03
Current Ratio	0.66	2.13	5.64	3.72	3.01
Quick Ratio	0.62	1.92	5.50	3.72	2.31
Interest Coverage	-32.71	-30.87	-19.05	--	2.08

Operating Efficiency Ratios

	JUPITER NEUROSCIENCES INC (JUNS)	Zai Lab - ADR	HUTCHMED (China) - ADR	DBV Technologies S.A. - ADR	Pharming Group N.V. ADS each representing 10 (PHAR)
Debtors to sales (%)	15.83	16.23	21.41	--	15.55
Asset Turnover	0.01	0.30	0.20	0.00	0.67
Receivable days	22.09	77.60	104.79	--	51.78
Inventory Days	6,897.10	109.55	49.57	--	492.02
Payable days	17,688.68	231.78	47.68	650.68	466.91
Cash Conversion Cycle	-10,769.48	-44.63	106.67	--	76.89

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly